Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (8 ops.)
Latest filing published 02 Jun 2023 for Biomea Fusion, Inc., €2.4M. Read the official filing
Filing timeline
BuySaleA2A Pharmaceuticals, Inc.
Insider track record
Disclosed buys
2
Disclosed sells
8
T+90 hit rate
0%
T+90 mean return
-25.6%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
A2A Pharmaceuticals, Inc.: trading record in brief
A2A Pharmaceuticals, Inc. discloses dealings in Biomea Fusion, Inc. to SEC (Form 4). Between 17 September 2021 and 31 May 2023, the trades on record add up to 10 filings.
Market trades split into 2 purchases (€741k) and 8 sales (€23.8M). The net balance comes to €23.0M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2023: no purchases and 6 sales on the market.
On 2 June 2023 came the latest disclosure, an open-market sale for €2.4M in Biomea Fusion, Inc. The latest purchase dates back some time: it was published 1,521 days ago, on 19 August 2022. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to A2A Pharmaceuticals, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
75,000 shares@ US$33.819.5% of flowCommon StockSEC:0001859061-23-000007:0
25,000 shares@ US$33.843.1% of flowCommon StockSEC:0001859061-23-000006:0
100,000 shares@ US$33.993112.4% of flowCommon StockSEC:0001859061-23-000005:0
200,000 shares@ US$29.118821.4% of flowCommon StockSEC:0001859061-23-000004:0
200,000 shares@ US$31.2523.1% of flowCommon StockSEC:0001859061-23-000002:0
200,000 shares@ US$31.2523.1% of flowCommon StockSEC:0001859061-23-000003:0
30,684 shares@ US$13.8721.7% of flowCommon StockSEC:0001859061-22-000002:0
Canonical exit: 14 Nov 2022 (T+90)
34,658 shares@ US$11.211.5% of flowCommon StockSEC:0001859061-22-000001:0
34,658 shares@ US$11.760.40% mcap37.5% of flowCommon StockSEC:0001856641-22-000001:0
34,658 shares@ US$10.961.7% of flowCommon StockSEC:0000899243-21-036769:0
Canonical exit: 16 Dec 2021 (T+90)
10 of 10 declarations
